{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:01:10Z","timestamp":1791414070161,"version":"4.3.3"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bpobgyn.2015.11.016","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T11:52:39Z","timestamp":1448452359000},"page":"85-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Role of Medical Management for Uterine Leiomyomas"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2731-3459","authenticated-orcid":false,"given":"Banafsheh N.","family":"Kashani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Centini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmt058","article-title":"Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations","volume":"20","author":"Segars","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","article-title":"Fibroids and infertility: an updated systematic review of the evidence","volume":"91","author":"Pritts","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2012.07.030","article-title":"Therapeutic management of uterine fibroid tumors: updated French guidelines","volume":"165","author":"Marret","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2015.11.016_bib7","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5858\/2000-124-1448-ROMCSA","article-title":"Relationship of myoma cell size and menopausal status in small uterine leiomyomas","volume":"124","author":"Cramer","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2015.11.016_bib8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard","year":"2011","journal-title":"Gut"},{"issue":"2 Pt 1","key":"10.1016\/j.bpobgyn.2015.11.016_bib9","first-page":"387","article-title":"Alternatives to hysterectomy in the management of leiomyomas","volume":"112","author":"American College of Obstetrics and Gynecology","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2009.02.006","article-title":"Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes","volume":"144","author":"De Falco","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2015.11.016_bib11","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/humrep\/16.8.1726","article-title":"Laparoscopic myomectomy: predicting the risk of conversion to an open procedure","volume":"16","author":"Dubuisson","year":"2001","journal-title":"Hum Reprod"},{"issue":"5728","key":"10.1016\/j.bpobgyn.2015.11.016_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bpobgyn.2015.11.016_bib13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1933719114533728","article-title":"Uterine fibroids: clinical manifestations and contemporary management","volume":"21","author":"Doherty","year":"2014","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ogc.2014.09.009","article-title":"Clinical management of leiomyoma","volume":"42","author":"Owen","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1 Pt 1","key":"10.1016\/j.bpobgyn.2015.11.016_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","article-title":"Progesterone: a critical role in the pathogenesis of uterine myomas","volume":"172","author":"Rein","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0015-0282(16)49332-5","article-title":"Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri","volume":"45","author":"Coddington","year":"1986","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib18","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2015.04.024","article-title":"Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms","volume":"104","author":"Tsigkou","year":"2015","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem.83.1.4503","article-title":"Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production","volume":"83","author":"Lee","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"13","key":"10.1016\/j.bpobgyn.2015.11.016_bib21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2165\/00003495-200363130-00008","article-title":"Tranexamic acid: a review of its use in the management of menorrhagia","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib22","first-page":"CD000400","article-title":"Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding","volume":"1","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/IJWH.S51083","article-title":"Uterine fibroids: current perspectives","volume":"6","author":"Khan","year":"2014","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib24","first-page":"20","article-title":"Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues","volume":"55","author":"Wilson","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1251483","article-title":"Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth","volume":"28","author":"Yoshida","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ogc.2005.12.014","article-title":"Options for medical treatment of myomas","volume":"33","author":"Rackow","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ogc.2012.09.005","article-title":"The impact and management of fibroids for fertility: an evidence-based approach","volume":"39","author":"Guo","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpobgyn.2008.03.001","article-title":"Medical management of fibroids","volume":"22","author":"Sankaran","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib30","series-title":"A\u00a0benefit-risk assessment of medical treatment for uterine leiomyoma","author":"De Leo","year":"2002"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0015-0282(97)81394-5","article-title":"Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata","volume":"67","author":"Deligdisc","year":"1997","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib32","first-page":"74","article-title":"A\u00a0putative role of versican in uterine leiomyomas","volume":"36","author":"Ohara","year":"2009","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2015.11.016_bib33","first-page":"3215","article-title":"Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in\u00a0vitro","volume":"81","author":"Chegini","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib34","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0006-291X(88)80430-3","article-title":"Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata","volume":"152","author":"Wiznitzer","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib35","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib36","first-page":"285","article-title":"Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids","volume":"8","author":"Biglia","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmig.2015.04.026","article-title":"Comparison of Laparoscopic myomectomy in large myomas with and without leuprolide acetate","author":"Chang","year":"2015","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib38","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.fertnstert.2009.05.070","article-title":"GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study","volume":"94","author":"Muzii","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jog.12135","article-title":"Single or repeated gonadotropin-releasing hormone agonist treatment avoids hysterectomy in premenopausal women with large symptomatic fibroids with no effects on sexual function","volume":"40","author":"Perrone","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0029-7844(95)00102-W","article-title":"GnRH agonist and iron versus placebo and ion in the anemic patient before surgery for leiomyomas: a randomized controlled trial","volume":"86","author":"Stovall","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejogrb.2012.07.023","article-title":"Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids","volume":"165","author":"Talaulikar","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1933719111432867","article-title":"Medical treatment of uterine leiomyoma","volume":"19","author":"Sabry","year":"2012","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2007.02.064","article-title":"Efficacy of tibolone as \u201cadd-back therapy\u201d in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids","volume":"89","author":"Morris","year":"2008","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0015-0282(98)00128-9","article-title":"A\u00a0clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata","volume":"70","author":"Palomba","year":"1998","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(16)58096-0","article-title":"The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)","volume":"65","author":"Lindsay","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib47","doi-asserted-by":"crossref","first-page":"943635","DOI":"10.1155\/2012\/943635","article-title":"Innovative oral treatments of uterine leiomyoma","volume":"2012","author":"Sabry","year":"2012","journal-title":"Obstet Gynecol Int"},{"issue":"9","key":"10.1016\/j.bpobgyn.2015.11.016_bib48","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/humrep\/12.9.2028","article-title":"Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix","volume":"12","author":"Gonzalez-Barcena","year":"1997","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1471-0528.2004.00504.x","article-title":"Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix","volume":"112","author":"Flierman","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009505.pub2","article-title":"Aromatase inhibitors for uterine fibroids","volume":"10","author":"Song","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6 Suppl.","key":"10.1016\/j.bpobgyn.2015.11.016_bib51","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.contraception.2007.01.025","article-title":"Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas","volume":"75","author":"Maruo","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/09513590.2013.769517","article-title":"The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids","volume":"29","author":"Machado","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0010-7824(02)00522-X","article-title":"The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia","volume":"67","author":"Mercorio","year":"2003","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib54","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0015-0282(03)00070-0","article-title":"Hemodynamic effect of danazol therapy in women with uterine leiomyomata","volume":"79","author":"La Marca","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib55","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.fertnstert.2004.08.004","article-title":"Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.bpobgyn.2015.11.016_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.biopha.2012.02.003","article-title":"Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERalpha, Src and P38 MAPK","volume":"66","author":"Zhu","year":"2012","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000293212","article-title":"Treatment of large fibroids with high doses of gestrinone","volume":"30","author":"Coutinho","year":"1990","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib58","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jc.2008-2327","article-title":"High aromatase expression in uterine leiomyoma tissues of African-American women","volume":"94","author":"Ishikawa","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2007.11.006","article-title":"Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients","volume":"91","author":"Hilario","year":"2009","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/S1472-6483(10)60246-5","article-title":"Treatment of symptomatic uterine leiomyoma with letrozole","volume":"17","author":"Gurates","year":"2008","journal-title":"Reproductive BioMedicine Online"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejogrb.2013.09.010","article-title":"Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women","volume":"171","author":"Duhan","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A\u00a0randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"Parsanezhad","year":"2010","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.bpobgyn.2015.11.016_bib63","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/oxfordjournals.humrep.a137937","article-title":"Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata","volume":"8","author":"Giudice","year":"1993","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib64","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/j.1460-2075.1988.tb02954.x","article-title":"Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours","volume":"7","author":"Hoppener","year":"1988","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/S0015-0282(00)01738-6","article-title":"Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata","volume":"75","author":"De Leo","year":"2001","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib66","first-page":"445","article-title":"Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression","volume":"28","author":"Melli","year":"2007","journal-title":"Saudi Med J"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0301-2115(00)00468-1","article-title":"The role of tamoxifen in the treatment of symptomatic uterine leiomyomata - a pilot study","volume":"996","author":"Sadan","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fertnstert.2003.06.009","article-title":"Raloxifene prevents the growth of uterine leiomyomas in premenopausal women","volume":"81","author":"Jirecek","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib69","first-page":"CD005287","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","volume":"10","author":"Deng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib70","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.fertnstert.2014.06.041","article-title":"With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?","volume":"102","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jsbmb.2010.05.005","article-title":"Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium","volume":"122","author":"Catherino","year":"2010","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2015.11.016_bib72","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12325-012-0042-8","article-title":"Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids","volume":"29","author":"Talaulikar","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib73","series-title":"Progesterone and progesterone receptor modulator in uterine leiomyoma growth. Translational research in uterine biology","author":"Ohara","year":"2008"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib75","series-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","author":"Donnez","year":"2012"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/IJWH.S15710","article-title":"Current and emerging treatments for uterine myoma - an update","volume":"3","author":"Duhan","year":"2011","journal-title":"Int J Womens Health"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib77","first-page":"513","article-title":"Regression of uterine leiomyomata in response to the antiprogesterone RU 486","volume":"76","author":"Murphy","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)57678-X","article-title":"Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect","volume":"64","author":"Murphy","year":"1995","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib79","first-page":"1154","article-title":"Low dose mifepristone in medical management of uterine leiomyoma - an experience from a tertiary care hospital from north India","volume":"137","author":"Kulshrestha","year":"2013","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.08.039","article-title":"Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis","volume":"100","author":"Shen","year":"2013","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib81","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.AOG.0000127622.63269.8b","article-title":"Systematic review of mifepristone for the treatment of uterine leiomyomata","volume":"103","author":"Steinauer","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib82","first-page":"Cd007687","article-title":"Mifepristone for uterine fibroids","volume":"8","author":"Tristan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1479-828X.2008.00931.x","article-title":"Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial","volume":"49","author":"Bagaria","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib84","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/12.4.815","article-title":"Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium","volume":"12","author":"Viville","year":"1997","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.bpobgyn.2015.11.016_bib85","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib86","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2006.11.094","article-title":"A\u00a0randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata","volume":"87","author":"Chwalisz","year":"2007","journal-title":"Fertil Steril"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2015.11.016_bib87","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1477-7827-4-S1-S8","article-title":"Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs)","volume":"4","author":"Chwalisz","year":"2006","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2015.11.016_bib88","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.fertnstert.2009.11.031","article-title":"The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells","volume":"93","author":"Luo","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib89","article-title":"Effects of a new progesterone receptor modulator, CDB-4124, on fibroid size and uterine bleeding","author":"Wiehle","year":"2008","journal-title":"US Obstetrics and Gynecology"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib90","series-title":"18th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)","first-page":"347","article-title":"The antiprogestin telapristone shrinks fibroids when used orally or as a vaginal suppository","author":"Wiehle","year":"2013"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib91","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"Nieman","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib93","first-page":"743","article-title":"Venous changes in the endometrium of myomatous uteri","volume":"38","author":"Farrer-Brown","year":"1971","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib94","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/humupd\/2.4.295","article-title":"Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era","volume":"2","author":"Stewart","year":"1996","journal-title":"Hum Reprod Update"},{"issue":"8","key":"10.1016\/j.bpobgyn.2015.11.016_bib95","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/PAS.0b013e318032125e","article-title":"Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas","volume":"31","author":"Ip","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00554669","article-title":"Pharmacokinetics and bioavailability of tranexamic acid","volume":"20","author":"Pilbrant","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib97","first-page":"621","article-title":"Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells","volume":"77","author":"Schatz","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib98","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2015.11.016_bib99","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1471-0528.2004.00158.x","article-title":"Evaluation of the effect of uterine artery embolisation on menstrual blood loss and uterine volume","volume":"111","author":"Khaund","year":"2004","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.bpobgyn.2015.11.016_bib100","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1210\/jc.2006-0724","article-title":"Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress","volume":"91","author":"Hickey","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib101","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/gme.0b013e318212499c","article-title":"Pharmacological therapy for abnormal uterine bleeding","volume":"18","author":"Pinkerton","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib102","first-page":"93","article-title":"Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study","volume":"5","author":"Sabry","year":"2013","journal-title":"Int J Womens Health"},{"issue":"8","key":"10.1016\/j.bpobgyn.2015.11.016_bib103","doi-asserted-by":"crossref","first-page":"E1374","DOI":"10.1210\/jc.2013-1777","article-title":"Vitamin D status in women with uterine leiomyomas","volume":"98","author":"Paffoni","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib104","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","article-title":"Vitamin d and the risk of uterine fibroids","volume":"24","author":"Baird","year":"2013","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2010.07.1041","article-title":"Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase","volume":"95","author":"Sharan","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib106","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.fertnstert.2008.02.136","article-title":"Vitamin D inhibits myometrial and leiomyoma cell proliferation in\u00a0vitro","volume":"91","author":"Blauer","year":"2009","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.bpobgyn.2015.11.016_bib107","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/humrep\/det265","article-title":"Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells","volume":"28","author":"Halder","year":"2013","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib108","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2010-2131","article-title":"1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells","volume":"96","author":"Halder","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib109","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1095\/biolreprod.111.098145","article-title":"1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model","volume":"86","author":"Halder","year":"2012","journal-title":"Biol Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2012.04.044","article-title":"Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells","volume":"98","author":"Mas","year":"2012","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib111","doi-asserted-by":"crossref","first-page":"e36935","DOI":"10.1371\/journal.pone.0036935","article-title":"Role of stem cells in human uterine leiomyoma growth","volume":"7","author":"Ono","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmu048","article-title":"Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications","volume":"21","author":"Moravek","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.bpobgyn.2015.11.016_bib113","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humupd\/dmt042","article-title":"The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy","volume":"20","author":"Tal","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib114","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/molehr\/gat007","article-title":"Gene expression analysis reveals an angiogenic profile in uterine leiomyoma pseudocapsule","volume":"19","author":"Di Tommaso","year":"2013","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"10.1016\/j.bpobgyn.2015.11.016_bib115","first-page":"779","article-title":"Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters","volume":"125","author":"Iyer","year":"1995","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.bpobgyn.2015.11.016_bib116","first-page":"w14139","article-title":"Idiopathic pulmonary fibrosis: the turning point is now!","volume":"145","author":"Funke","year":"2015","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"10.1016\/j.bpobgyn.2015.11.016_bib117","doi-asserted-by":"crossref","first-page":"H512","DOI":"10.1152\/ajpheart.00137.2015","article-title":"Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts","volume":"309","author":"Yamagami","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2015.11.016_bib118","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-06-1811","article-title":"Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats","volume":"13","author":"Laping","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.bpobgyn.2015.11.016_bib119","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/humupd\/dmu017","article-title":"MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?","volume":"20","author":"Karmon","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.bpobgyn.2015.11.016_bib120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/humupd\/dml015","article-title":"Gene therapy and uterine leiomyoma: a review","volume":"12","author":"Al-Hendy","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib121","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.fertnstert.2008.09.086","article-title":"Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model","volume":"93","author":"Hassan","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2015.11.016_bib122","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000209675","article-title":"Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene\/ganciclovir shrinks uterine leiomyoma in the Eker rat model","volume":"68","author":"Hassan","year":"2009","journal-title":"Gynecol Obstet Invest"},{"issue":"9","key":"10.1016\/j.bpobgyn.2015.11.016_bib123","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/humrep\/det275","article-title":"Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas","volume":"28","author":"Nair","year":"2013","journal-title":"Hum Reprod"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693415002308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693415002308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T01:01:12Z","timestamp":1653613272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693415002308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":123,"alternative-id":["S1521693415002308"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.016","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Medical Management for Uterine Leiomyomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}